2-(methylazaniumyl)-3-[(2-methylpropan-2-yl)oxy]butanoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(methylazaniumyl)-3-[(2-methylpropan-2-yl)oxy]butanoate
• 化学式: C9H19NO3
• 分子量: 189.25
• InChiKey: KYXQLWFONOUGLB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• PTERIDINONE COMPOUNDS AND USES THEREOF
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20190322673A1

  公开（公告）日：2019-10-24

  The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

  本发明提供了式I的化合物或其药学上可接受的盐，以及用于治疗细胞增殖性疾病（例如癌症）的药物组合物和使用方法。
• Kit for Highly Sensitive Detection Assays
  申请人：Bade Steffen

  公开号：US20090104633A1

  公开（公告）日：2009-04-23

  The present invention relates to kits comprising 2,4-dichlorophenoxyacetate derivatives as well as antibodies that bind to these derivatives. Inter alia, the kits can be used to label biomolecules for analytical and diagnostic applications. Some of the compounds described here can be used to label biomolecules under physiological conditions and without having to apply in situ activation. Furthermore, the presence of spacers within the 2,4-dichlorophenoxyacetate derivatives improves their binding to antibodies.

  本发明涉及包含2,4-二氯苯氧乙酸衍生物及与其结合的抗体的试剂盒。其中，这些试剂盒可用于标记生物分子以进行分析和诊断应用。这里描述的一些化合物可在生理条件下用于标记生物分子，而无需进行原位激活。此外，2,4-二氯苯氧乙酸衍生物中存在的空间支链改善了它们与抗体的结合。
• Pteridinone compounds and uses thereof
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US11059826B2

  公开（公告）日：2021-07-13

  The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

  本发明提供了式 I 的化合物或其药学上可接受的盐、其药物组合物及其用于治疗细胞增殖性疾病（如癌症）的方法。
• Methods for Determining the Cleavability of Substrates
  申请人：Gorris Hans-Heiner

  公开号：US20090258381A1

  公开（公告）日：2009-10-15

  The invention relates to methods for examining the enzymatic cleavability of substrates. In the methods, compounds, which have a cleavability of the section to be examined, are firstly synthesized on a first solid phase, separated therefrom, the cleavage reaction is carried out in solution and the cleaved and uncleaved compounds are immobilized on a second solid phase and the cleavability is determined.